ImportRefusal LogoImportRefusal

GALDERMA

⚠️ Moderate Risk

FEI: 3013067037 • Uppsala, Uppsala Lan • SWEDEN

FEI

FEI Number

3013067037

📍

Location

Uppsala, Uppsala Lan

🇸🇪

Country

SWEDEN
🏢

Address

Seminariegatan 21, , Uppsala, Uppsala Lan, Sweden

Moderate Risk

FDA Import Risk Assessment

46.0
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

5
Total Refusals
6
Unique Violations
8/7/2024
Latest Refusal
3/15/2019
Earliest Refusal

Score Breakdown

Violation Severity
62.5×40%
Refusal Volume
28.8×30%
Recency
57.0×20%
Frequency
9.3×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

2374×

NO PMA

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that the device appears to be a Class III device and does not appear to have in effect an approved application for premarket approval pursuant to Section 515 of the Act, or an exemption pursuant to Section 520(g)(1).

32804×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

3411×

REGISTERED

It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).

5081×

NO 510(K)

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.

Refusal History

DateProductViolationsDivision
8/7/2024
53LY06MOISTURIZING (SKIN CARE PREPARATIONS)
118NOT LISTED
237NO PMA
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
8/5/2024
53YY99OTHER COSMETIC AND COSMETIC PRODUCTS, N.E.C.
118NOT LISTED
237NO PMA
3280FRNMFGREG
75UNAPPROVED
Division of Southeast Imports (DSEI)
1/19/2024
79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
237NO PMA
3280FRNMFGREG
341REGISTERED
Division of Northern Border Imports (DNBI)
1/12/2024
79LMHIMPLANT, DERMAL, COLLAGEN FOR AESTHETIC USE
118NOT LISTED
237NO PMA
Division of Southeast Imports (DSEI)
3/15/2019
79MDDDEVICE, DERMAL REPLACEMENT
118NOT LISTED
3280FRNMFGREG
508NO 510(K)
Division of Northern Border Imports (DNBI)

Frequently Asked Questions

What is GALDERMA's FDA import refusal history?

GALDERMA (FEI: 3013067037) has 5 FDA import refusal record(s) in our database, spanning from 3/15/2019 to 8/7/2024.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. GALDERMA's FEI number is 3013067037.

What types of violations has GALDERMA received?

GALDERMA has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about GALDERMA come from?

All FDA import refusal data for GALDERMA is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.